Lunai Bioworks

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lunai Bioworks and other ETFs, options, and stocks.

About LNAI

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. 

CEO
David Weinstein
CEODavid Weinstein
Employees
29
Employees29
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
2011
Founded2011
Employees
29
Employees29

LNAI Key Statistics

Market cap
26.04M
Market cap26.04M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
170.02K
Average volume170.02K
High today
$1.15
High today$1.15
Low today
$1.02
Low today$1.02
Open price
$1.04
Open price$1.04
Volume
182.63K
Volume182.63K
52 Week high
$21.00
52 Week high$21.00
52 Week low
$0.902
52 Week low$0.902

People also own

Based on the portfolios of people who own LNAI. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.